Drug Binding to BamA Targets Its Lateral Gate
The Journal of Physical Chemistry B · 31.08.2023 · 127 (34) · 7509-7517
DOI: 10.1021/acs.jpcb.3c04501 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Physical Chemistry B, online erschienen am 17.08.2023. Verfasst von Katie M Kuo und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry and Biochemistry, Georgia Institute of Technology, Atlanta, Georgia 30332, United States. Hauptthemen laut MEDLINE: Protein Folding, Membrane Proteins. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, Office of Advanced Cyberinfrastructure, U.S. Department of Education.
Abstract (Originalsprache)
BamA, the core component of the β-barrel assembly machinery (BAM) complex, is an outer-membrane protein (OMP) in Gram-negative bacteria. Its function is to insert and fold substrate OMPs into the outer membrane (OM). Evidence suggests that BamA follows the asymmetric hybrid-barrel model where the first and last strands of BamA separate, a process known as lateral gate opening, to allow nascent substrate OMP β-strands to sequentially insert and fold through β-augmentation. Recently, multiple lead compounds that interfere with BamA's function have been identified. We modeled and then docked one of these compounds into either the extracellular loops of BamA or the open lateral gate. With the compound docked in the loops, we found that the lateral gate remains closed during 5 μs molecular dynamics simulations. The same compound when docked in the open lateral gate stays bound to the β16 strand of BamA during the simulation, which would prevent substrate OMP folding. In addition, we simulated mutants of BamA that are resistant to one or more of the identified lead compounds. In these simulations, we observed a differing degree and/or frequency of opening of BamA's lateral gate compared to BamA-apo, suggesting that the mutations grant resistance by altering the dynamics at the gate. We conclude that the compounds act by inhibiting BamA lateral gate opening and/or binding of substrate, thus preventing subsequent OMP folding and insertion.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Chemistry and Biochemistry, Georgia Institute of Technology, Atlanta, Georgia 30332, United States.
- Department of Molecular Biophysics and Biochemistry (MB&B), Yale University, New Haven, Connecticut 06510, United States.
- School of Physics, Georgia Institute of Technology, Atlanta, Georgia 30332, United States.
ORCID-Profile: James C Gumbart
Förderung
- NIGMS NIH HHS
- Office of Advanced Cyberinfrastructure
- U.S. Department of Education
- National Institute of General Medical Sciences
Zitieren
APA
Kuo, K. M., Liu, J., Pavlova, A., & Gumbart, J. C. (2023). Drug Binding to BamA Targets Its Lateral Gate. The Journal of Physical Chemistry B, 127(34), 7509-7517. https://doi.org/10.1021/acs.jpcb.3c04501
Vancouver
Kuo KM, Liu J, Pavlova A, Gumbart JC. Drug Binding to BamA Targets Its Lateral Gate. The Journal of Physical Chemistry B. 2023;127(34):7509-7517. doi:10.1021/acs.jpcb.3c04501
BibTeX
@article{Kuo2023,
author = {Kuo, Katie M and Liu, Jinchan and Pavlova, Anna and Gumbart, James C},
title = {Drug Binding to BamA Targets Its Lateral Gate},
journal = {The Journal of Physical Chemistry B},
year = {2023},
volume = {127},
number = {34},
pages = {7509--7517},
doi = {10.1021/acs.jpcb.3c04501}
}
EUVIMED